Lowering Drug Prices by Once Again Putting Americans First

First Administration delivered aggressive drug price actions; Biden Administration reversed progress; Inflation Reduction Act produced lower savings than projected.

Federal health programs optimized to provide lower prescription drug access to patients and taxpayers.

Secretary proposes improved guidance within 60 days; Assistant works on Part D premium stabilization; Secretary seeks congressional modification of small molecule treatment.

Secretary develops and tests payment model within one year to improve Medicare value for high-cost drugs.

Secretary publishes plan within 180 days for hospital acquisition cost survey and proposes appropriate adjustments.

Officials provide recommendations within 180 days on ensuring accurate rebates, promoting innovation, and supporting state spending management.

Secretary conditions future health center grants on establishing practices making insulin and epinephrine available at discounted rates within 90 days.

Officials provide recommendations within 90 days on promoting competitive, efficient pharmaceutical value chains.

FDA Commissioner issues report within 180 days on accelerating generics, biosimilars, and over-the-counter reclassification.

FDA Commissioner streamlines importation program within 90 days for state approval without sacrificing safety.

Secretary evaluates whether Medicare payment encourages hospital department shifts and proposes regulations within 180 days.

Secretary of Labor proposes PBM transparency regulations within 180 days.

Secretary conducts joint listening sessions and issues report with anti-competitive recommendations within 180 days.

Standard boilerplate: preserves existing agency authority, conditions the order on appropriations, and creates no enforceable private rights.